RAC 3.77% $1.53 race oncology ltd

Dr T didn’t say there were no interdependencies or delays. It...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 11,249 Posts.
    lightbulb Created with Sketch. 29638
    Dr T didn’t say there were no interdependencies or delays. It was @ma420 that stated this here.

    I do think DrT’s response was unintentionally ambiguous. “Data” in the context of his response would have been final readouts.

    “Data” for the purpose of trial design is perhaps interim analysis based on a smaller number of patients. I don’t think they would need data from all 50 patients to get a “feel” for parameters to use to
    design the cardioprotection trial.

    Also recognise that recruitment criteria for the observational study is fairly narrow … two or more cardiac risk factors. This means that all of the patients recruited into the observational study will generate data that can contribute in some way to trial design ( once analysed for say the first dozen or so patients ).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.